Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Up 4,427.0% in May

Arcadia Biosciences, Inc. (NASDAQ:RKDA) saw a significant increase in short interest in May. As of May 29th, there was short interest totaling 411,143 shares, an increase of 4,427.0% from the May 14th total of 9,082 shares. Currently, 21.8% of the shares of the stock are sold short. Based on an average daily volume of 6,750,071 shares, the days-to-cover ratio is currently 0.1 days.

Arcadia Biosciences Trading Down 0.2%

Shares of RKDA traded down $0.00 during trading hours on Wednesday, hitting $0.92. 2,226 shares of the stock traded hands, compared to its average volume of 603,348. The business has a fifty day moving average of $1.11 and a 200-day moving average of $1.98. The firm has a market capitalization of $1.89 million, a PE ratio of -0.16 and a beta of 0.51. Arcadia Biosciences has a 1-year low of $0.80 and a 1-year high of $6.71.

Arcadia Biosciences (NASDAQ:RKDA) last announced its quarterly earnings data on Thursday, May 14th. The basic materials company reported ($2.11) earnings per share for the quarter, missing the consensus estimate of ($0.80) by ($1.31). Arcadia Biosciences had a negative return on equity of 113.73% and a negative net margin of 195.94%.The firm had revenue of $1.10 million for the quarter, compared to the consensus estimate of $1.60 million.

Analysts Set New Price Targets

Separately, Weiss Ratings lowered shares of Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, May 21st. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has an average rating of “Sell”.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.